The Community Resource in Targeted Therapies
Driving Knowledge. Empowering Change. Optimizing Outcomes.
ONCAlert | Upfront Therapy for mRCC

Dr. Minesh Mehta Talks About A Newly-Approved Device To Treat Glioblastoma

Published Online: 4:17 PM, Tue October 20, 2015


Minesh Mehta, MBChB, medical director, Maryland Proton Treatment Center, talks about Optune, the recently FDA-approved device used to treat newly diagnosed glioblastoma. The system utilizes alternating electric fields to inhibit tumor cell growth.


Mehta says that he hopes the device will become more widespread in the future after more research comes out about its clinical benefit.

Copyright © TargetedOnc 2018 Intellisphere, LLC. All Rights Reserved.